Annexin A1 in the brain - undiscovered roles?

Trends in Pharmacological Sciences

Volumn 29, Issue 3, 2008, Pages 135-142

  Solito, Egle ^a   McArthur, Simon ^a   Christian, Helen ^b   Gavins, Felicity ^a   Buckingham, Julia C ^a   Gillies, Glenda E ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; LIPOCORTIN 1;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN INJURY; EPENDYMA CELL; GLIA CELL; HUMAN; INNATE IMMUNITY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; VASCULAR TISSUE;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; BRAIN; HUMANS; NERVOUS SYSTEM DISEASES; RECEPTORS, FORMYL PEPTIDE;

EID: 39749190566     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.12.003     Document Type: Review

References (89)

1. Moss S.E., and Morgan R.O. The annexins. Genome Biol. 5 (2004) 219
2. 2+-dependent phospholipid binding and phosphorylation of lipocortin I. J. Biol. Chem. 262 (1987) 6931-6937
3. Buckingham J.C., et al. Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann. N. Y. Acad. Sci. 1088 (2006) 396-409
4. Solito E., et al. Human annexin 1 is highly expressed during the differentiation of the human epithelial cell line A 549. Involvement of NF-IL6 in phorbol ester induction of annexin 1. Cell Growth Differ. 9 (1998) 327-336
5. de Coupade C., et al. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 31 (2000) 371-380
6. McNeil A.K., et al. Requirement for annexin A1 in plasma membrane repair. J. Biol. Chem. 281 (2006) 35202-35207
7. McKanna J.A. Lipocortin 1 in apoptosis:mammary regression. Anat. Rec. 242 (1995) 1-10
8. Solito E., et al. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br. J. Pharmacol. 133 (2001) 217-228
9. Lim L.H., et al. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14535-14539
10. Fan X., et al. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol. Biol. Cell 15 (2004) 2863-2872
11. Flower R.J. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94 (1988) 987-1015
12. Bastian B.C., et al. Autoantibodies to annexins: a diagnostic marker for cutaneous disorders?. J. Dermatol. Sci. 8 (1994) 194-202
13. Rothwell N., et al. The role of interleukin 1 in acute neurodegeneration and stroke:pathophysiological and therapeutuc implications. J. Clin. Invest. 100 (1997) 2648-2652
14. Gavins F.N., et al. Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J. 21 (2007) 1751-1758
15. Rothwell N.J., and Relton J.K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. 17 (1993) 217-227
16. Young K.A., et al. De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum. Glia 26 (1999) 333-343
17. Smith T., et al. Lipocortins 1, 2 and 5 in the central nervous system and pituitary gland of the rat: selective induction by dexamethasone of lipocortin 1 in the anterior pituitary gland. Mol. Neuropharmacol. 3 (1993) 45-55
18. Woods M.D., et al. Localization of lipocortin-1 in rat hypothalamus and pituitary gland. Biochem. Soc. Trans. 18 (1990) 1236-1237
19. McKanna J.A., and Zhang M.Z. Immunohistochemical localization of lipocortin 1 in rat brain is sensitive to pH, freezing, and dehydration. J. Histochem. Cytochem. 45 (1997) 527-538
20. Johnson M.D., et al. Lipocortin-1 immunoreactivity in the normal human central nervous system and lesions with astrocytosis. Am. J. Clin. Pathol. 92 (1989) 424-429
21. Dreier R., et al. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem. Cell Biol. 110 (1998) 137-148
22. Gabrion J.B., et al. Ependymal and choroidal cells in culture: characterization and functional differentiation. Microsc. Res. Tech. 41 (1998) 124-157
23. Markoff A., and Gerke V. Expression and functions of annexins in the kidney. Am. J. Physiol. Renal Physiol. 289 (2005) F949-F956
24. Savchenko V.L., et al. Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience 96 (2000) 195-203
25. Johnson M.D., et al. Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors. Hum. Pathol. 20 (1989) 772-776
26. Eberhard D.A., et al. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am. J. Pathol. 145 (1994) 640-649
27. Farooqui A.A., et al. Modulation of inflammation in brain: a matter of fat. J. Neurochem. 101 (2007) 577-599
28. Marchetti B., and Abbracchio M.P. To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?. Trends Pharmacol. Sci. 26 (2005) 517-525
29. Magnus T., et al. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J. Immunol. 167 (2001) 5004-5010
30. Liu B., et al. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 111 (2003) 1065-1073
31. Herbert S.P., et al. The Confluence-dependent Interaction of Cytosolic Phospholipase A2-{alpha} with Annexin A1 Regulates Endothelial Cell Prostaglandin E2 Generation. J. Biol. Chem. 282 (2007) 34468-34478
32. McKanna J.A. Lipocortin 1 immunoreactivity identifies microglia in adult rat brain. J. Neurosci. Res. 36 (1993) 491-500
33. Knott C., et al. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol. Cell. Neurosci. 16 (2000) 724-739
34. Hannon R., et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J. 17 (2003) 253-255
35. Fava R.A., et al. Lipocortin 1 (p35) is abundant in a restricted number of differentiated cell types in adult organs. J. Cell. Physiol. 141 (1989) 284-293
36. Hamre K.M., et al. The annexins: specific markers of midline structures and sensory neurons in the developing murine central nervous system. J. Comp. Neurol. 352 (1995) 421-435
37. McKanna J.A. Optic chiasm and infundibular decussation sites in the developing rat diencephalon are defined by glial raphes expressing p35 (lipocortin 1, annexin I). Dev. Dyn. 195 (1992) 75-86
38. Parente L., and Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm. Res. 53 (2004) 125-132
39. Elderfield A.J., et al. Lipocortins (annexins) 1, 2, 4 and 5 are increased in the central nervous system in multiple sclerosis. J. Neuroimmunol. 39 (1992) 91-100
40. Probst-Cousin S., et al. Expression of annexin-1 in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 28 (2002) 292-300
41. Williams A.E., et al. Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 654 (1994) 200-206
42. Williams A., et al. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754 (1997) 171-180
43. Barber P.A., et al. MR molecular imaging of early endothelial activation in focal ischemia. Ann. Neurol. 56 (2004) 116-120
44. Mullens L., et al. Up-regulation of lipocortin-1 and its mRNA in reactive astrocytes in kainate-lesioned rat cerebellum. J. Neuroimmunol. 50 (1994) 25-33
45. Hirst W.D., et al. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. Mol. Cell. Neurosci. 13 (1999) 57-68
46. Minghetti L., et al. Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br. J. Pharmacol. 126 (1999) 1307-1314
47. Black M.D., et al. Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Brain Res. 585 (1992) 135-140
48. Relton J.K., et al. Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J. Exp. Med. 174 (1991) 305-310
49. Huitinga I., et al. Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat. Clin. Exp. Immunol. 111 (1998) 198-204
50. Bolton C., et al. The detection of lipocortins 1, 2 and 5 in central nervous system tissues from Lewis rats with acute experimental allergic encephalomyelitis. J. Neuroimmunol. 29 (1990) 173-181
51. Damazo A.S., et al. Analysis of annexin 1 expression in rat trachea: study of the mast cells heterogeneity. Annexins 1 (2004) 12-18
52. Dietrich W.D., et al. Microvascular and neuronal consequences of common carotid artery thrombosis and platelet embolization in rats. J. Neuropathol. Exp. Neurol. 52 (1993) 351-360
53. Kwon E.E., and Prineas J.W. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J. Neuropathol. Exp. Neurol. 53 (1994) 625-636
54. Stevens S.L., et al. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res. 932 (2002) 110-119
55. Izikson L., et al. Targeting monocyte recruitment in CNS autoimmune disease. Clin. Immunol. 103 (2002) 125-131
56. Mima T., and Shigeno T. Lipocortin-1 fails to ameliorate cold-injury brain edema in the rat. Acta Neurochir. Suppl. 76 (2000) 307-310
57. D'Acquisto F., et al. Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur. J. Immunol. 37 (2007) 3131-3142
58. Galea I., et al. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
59. Solito E., et al. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17 (2003) 1544-1546
60. Perretti M., and Solito E. Annexin 1 and neutrophil apoptosis. Biochem. Soc. Trans. 32 (2004) 507-510
61. Yona S., et al. Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages. Br. J. Pharmacol. 142 (2004) 890-898
62. Arur S., et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4 (2003) 587-598
63. Hayhoe R.P., et al. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107 (2006) 2123-2130
64. Solito E., et al. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J. 20 (2006) 1498-1500
65. Perretti M., and D'Acquisto F. Novel aspects of annexin 1 and glucocorticoid biology: intersection with nitric oxide and the lipoxin receptor. Inflamm. Allergy Drug Targets 5 (2006) 107-114
66. Lucas S.M., et al. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (2006) S232-S240
67. Perry V.H., et al. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7 (2007) 161-167
68. Nguyen M.D., et al. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24 (2004) 1340-1349
69. De Caterina R., et al. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J. Appl. Physiol. 75 (1993) 2368-2375
70. Carey F., et al. Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am. J. Physiol. 259 (1990) R266-R269
71. Strijbos P.J., et al. Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am. J. Physiol. 263 (1992) E632-E636
72. Davidson J., et al. Antipyretic actions of human recombinant lipocortin-1. Br. J. Pharmacol. 102 (1991) 7-9
73. Strijbos P.J., et al. Impaired febrile response of aging mice are mediated by endogenous lipocortin-1 (annexin-1). Am. J. Physiol. 265 (1993) E289-E297
74. Mogi M., et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180 (1994) 147-150
75. Muller T., et al. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease. Acta Neurol. Scand. 98 (1998) 142-144
76. Taylor A.D., et al. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms. Neuroendocrinology 62 (1995) 530-542
77. Philip J.G., et al. Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1. Br. J. Pharmacol. 134 (2001) 887-895
78. Barnes J.A., and Gomes A.V. Proteolytic signals in the primary structure of annexins. Mol. Cell. Biochem. 231 (2002) 1-7
79. Andersson P.B., et al. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48 (1992) 169-186
80. Murphy P.M., et al. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267 (1992) 7637-7643
81. Chiang N., et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58 (2006) 463-487
82. Gao J.L., and Murphy P.M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 268 (1993) 25395-25401
83. Takano T., et al. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185 (1997) 1693-1704
84. Cui Y., et al. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 72 (2002) 628-635
85. Lacy M., et al. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61 (1995) 71-78
86. Boulant J.A. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin. Infect. Dis. 31 Suppl 5 (2000) S157-S161
87. Walther A., et al. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5 (2000) 831-840
88. Gibbs L., et al. Time-dependent expression of annexin 1 in a model of chronic granulomatous inflammation. Inflamm. Res. 51 (2002) 300-306
89. Ernst S., et al. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J. Immunol. 172 (2004) 7669-7676